Helius Medical Technologies, Inc. Class A Common Stock (DE), also called Helius Medical, is a neurotech company in the medical device industry that focuses on neurological wellness. Read More The firm develops, licenses and acquires non-invasive platform technologies that amplify the brain’s ability to heal itself and reduce symptoms of neurological disease or trauma. It engages in the development of the investigational Portable Neuromodulation Stimulator (PoNS), that delivers neurostimulation via the tongue which has been shown in clinical studies to enhance the effectiveness of physical exercises in people with neurological symptoms from disease or trauma such as mild-to-moderate traumatic brain injury. The company was founded in 2014 and is headquartered in Newtown, PA. The listed name for HSDT is Helius Medical Technologies, Inc. Class A Common Stock (DE).